Client News
Industry knowledge and expertise are core components of the Trout Group’s investor relations platform. We provide our clients with valuable insight into the developments impacting their businesses and investment potential.
4SC AG
Ablynx NV
Addex Pharmaceuticals
Agennix AG
Algeta ASA
Amarin Pharma Inc.
Aoxing Pharmaceutical Co.
Avanir Pharmaceuticals
Biodel Inc.
Bionomics Limited
BioSante Pharmaceuticals
Biosign Technologies Inc.
Biotie Therapies
Boehringer Ingelheim
Capstone Therapeutics
Cell Therapeutics, Inc.
Cellectis SA
Celsion Corporation
Chiral Quest Corp.
Circadian Technologies Limited
Columbia Laboratories, Inc.
Coronado Biosciences, Inc.
CPEX Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc.
Dynavax Technologies Corp.
ENZO Biochem, Inc.
Enzon Pharmaceuticals, Inc.
Epigenomics AG
Genetic Technologies Ltd
Gentium S.P.A.
GW Pharmaceuticals
iCo Therapeutics Inc.
Inhibitex, Inc.
Intercell AG
MagForce Nanotechnologies AG
Marshall Edwards Inc.
MediGene AG
Morphosys AG
OICR
Oxford BioMedica plc
Paion AG
Pharmacyclics, Inc.
Pharming Group N.V.
Prima Biomed Ltd.
Prosensa Therapeutics B.V.
Protalix BioTherapeutics
QLT Inc.
Raptor Pharmaceutical Corp.
Reata Pharmaceuticals Inc.
Redpoint Bio Corporation
Response Biomedical Corp.
Response Genetics, Inc.
Rockwell Medical, Inc.
SDIX
Stratec Biomedical Systems AG
Sunway Global Inc
SuperGen, Inc.
VIVUS Inc.
Wilex AG
YM BioSciences, Inc.